Abstract
Because of the important roles noncoding RNAs play in gene expression, their sequence-specific recognition is important for both fundamental science and the pharmaceutical industry. However, most noncoding RNAs fold in complex helical structures that are challenging problems for molecular recognition. Herein, we describe a method for sequence-specific recognition of double-stranded RNA using peptide nucleic acids (PNAs) that form triple helices in the major grove of RNA under physiologically relevant conditions. We also outline methods for solid-phase conjugation of PNA with cell-penetrating peptides and fluorescent dyes. Protocols for PNA preparation and binding studies using isothermal titration calorimetry are described in detail.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cech TR, Steitz JA (2014) The noncoding RNA revolution-trashing old rules to forge new ones. Cell 157:77–94
Lee JT (2012) Epigenetic regulation by long noncoding RNAs. Science 338:1435–1439
Yoon J-H, Abdelmohsen K, Gorospe M (2013) Posttranscriptional gene regulation by long noncoding RNA. J Mol Biol 425:3723–3730
Gorski SA, Vogel J, Doudna JA (2017) RNA-based recognition and targeting: sowing the seeds of specificity. Nat Rev Mol Cell Biol 18:215–228
Consortium IHGS (2004) Finishing the euchromatic sequence of the human genome. Nature 431:931–945
Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F, Xue C, Marinov GK, Khatun J, Williams BA, Zaleski C, Rozowsky J, Roeder M, Kokocinski F, Abdelhamid RF, Alioto T, Antoshechkin I, Baer MT, Bar NS, Batut P, Bell K, Bell I, Chakrabortty S, Chen X, Chrast J, Curado J, Derrien T, Drenkow J, Dumais E, Dumais J, Duttagupta R, Falconnet E, Fastuca M, Fejes-Toth K, Ferreira P, Foissac S, Fullwood MJ, Gao H, Gonzalez D, Gordon A, Gunawardena H, Howald C, Jha S, Johnson R, Kapranov P, King B, Kingswood C, Luo OJ, Park E, Persaud K, Preall JB, Ribeca P, Risk B, Robyr D, Sammeth M, Schaffer L, See L-H, Shahab A, Skancke J, Suzuki AM, Takahashi H, Tilgner H, Trout D, Walters N, Wang H, Wrobel J, Yu Y, Ruan X, Hayashizaki Y, Harrow J, Gerstein M, Hubbard T, Reymond A, Antonarakis SE, Hannon G, Giddings MC, Ruan Y, Wold B, Carninci P, Guigo R, Gingeras TR (2012) Landscape of transcription in human cells. Nature 489:101–108
Amitai G, Sorek R (2016) CRISPR-Cas adaptation: insights into the mechanism of action. Nat Rev Microbiol 14:67–76
Marraffini LA (2015) CRISPR-Cas immunity in prokaryotes. Nature 526:55–61
Wright AV, Nunez JK, Doudna JA (2016) Biology and applications of CRISPR systems: harnessing nature’s toolbox for genome engineering. Cell 164:29–44
Nielsen PE, Egholm M, Berg RH, Buchardt O (1991) Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science 254:1497–1500
Egholm M, Buchardt O, Nielsen PE, Berg RH (1992) Peptide nucleic acids (PNA). Oligonucleotide analogs with an achiral peptide backbone. J Am Chem Soc 114:1895–1897
Chow CS, Bogdan FM (1997) A structural basis for RNA-ligand interactions. Chem Rev 97:1489–1513
Sucheck SJ, Wong CH (2000) RNA as a target for small molecules. Curr Opin Chem Biol 4:678–686
Thomas JR, Hergenrother PJ (2008) Targeting RNA with small molecules. Chem Rev 108:1171–1224
Guan L, Disney MD (2012) Recent advances in developing small molecules targeting RNA. ACS Chem Biol 7:73–86
Shortridge MD, Varani G (2015) Structure based approaches for targeting non-coding RNAs with small molecules. Curr Opin Struct Biol 30:79–88
Velagapudi SP, Vummidi BR, Disney MD (2015) Small molecule chemical probes of microRNA function. Curr Opin Chem Biol 24:97–103
Childs-Disney JL, Disney MD (2016) Approaches to validate and manipulate RNA targets with small molecules in cells. Annu Rev Pharmacol Toxicol 56:123–140
Howe JA, Wang H, Fischmann TO, Balibar CJ, Xiao L, Galgoci AM, Malinverni JC, Mayhood T, Villafania A, Nahvi A, Murgolo N, Barbieri CM, Mann PA, Carr D, Xia E, Zuck P, Riley D, Painter RE, Walker SS, Sherborne B, de Jesus R, Pan W, Plotkin MA, Wu J, Rindgen D, Cummings J, Garlisi CG, Zhang R, Sheth PR, Gill CJ, Tang H, Roemer T (2015) Selective small-molecule inhibition of an RNA structural element. Nature 526:672–677
Palacino J, Swalley SE, Song C, Cheung AK, Shu L, Zhang X, Van Hoosear M, Shin Y, Chin DN, Keller CG, Beibel M, Renaud NA, Smith TM, Salcius M, Shi X, Hild M, Servais R, Jain M, Deng L, Bullock C, McLellan M, Schuierer S, Murphy L, Blommers MJJ, Blaustein C, Berenshteyn F, Lacoste A, Thomas JR, Roma G, Michaud GA, Tseng BS, Porter JA, Myer VE, Tallarico JA, Hamann LG, Curtis D, Fishman MC, Dietrich WF, Dales NA, Sivasankaran R (2015) SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice. Nat Chem Biol 11:511–517
Barros SA, Chenoweth DM (2014) Recognition of nucleic acid junctions using triptycene-based molecules. Angew Chem Int Ed 53:13746–13750
Wong C-H, Nguyen L, Peh J, Luu LM, Sanchez JS, Richardson SL, Tuccinardi T, Tsoi H, Chan WY, Chan HYE, Baranger AM, Hergenrother PJ, Zimmerman SC (2014) Targeting toxic RNAs that cause myotonic dystrophy type 1 (DM1) with a bisamidinium inhibitor. J Am Chem Soc 136:6355–6361
Nguyen L, Luu LM, Peng S, Serrano JF, Chan HYE, Zimmerman SC (2015) Rationally designed small molecules that target both the DNA and RNA causing myotonic dystrophy type 1. J Am Chem Soc 137:14180–14189
Arambula JF, Ramisetty SR, Baranger AM, Zimmerman SC (2009) A simple ligand that selectively targets CUG trinucleotide repeats and inhibits MBNL protein binding. Proc Natl Acad Sci U S A 106:16068–16073
Gareiss PC, Sobczak K, McNaughton BR, Palde PB, Thornton CA, Miller BL (2008) Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1). J Am Chem Soc 130:16254–16261
Rzuczek SG, Colgan LA, Nakai Y, Cameron MD, Furling D, Yasuda R, Disney MD (2017) Precise small-molecule recognition of a toxic CUG RNA repeat expansion. Nat Chem Biol 13:188–193
Davidson A, Leeper TC, Athanassiou Z, Patora-Komisarska K, Karn J, Robinson JA, Varani G (2009) Simultaneous recognition of HIV-1 TAR RNA bulge and loop sequences by cyclic peptide mimics of Tat protein. Proc Natl Acad Sci U S A 106:11931–11936
Abulwerdi FA, Shortridge MD, Sztuba-Solinska J, Wilson R, Le Grice SFJ, Varani G, Schneekloth JS (2016) Development of small molecules with a noncanonical binding mode to HIV-1 trans activation response (TAR) RNA. J Med Chem 59:11148–11160
Hilimire TA, Chamberlain JM, Anokhina V, Bennett RP, Swart O, Myers JR, Ashton JM, Stewart RA, Featherston AL, Gates K, Helms ED, Smith HC, Dewhurst S, Miller BL (2017) HIV-1 frameshift RNA-targeted triazoles inhibit propagation of replication-competent and multi-drug-resistant HIV in human cells. ACS Chem Biol 12:1674–1682
McNaughton BR, Gareiss PC, Miller BL (2007) Identification of a selective small-molecule ligand for HIV-1 frameshift-inducing stem-loop RNA from an 11,325 member resin bound dynamic combinatorial library. J Am Chem Soc 129:11306–11307
Gumireddy K, Young DD, Xiong X, Hogenesch JB, Huang Q, Deiters A (2008) Small-molecule inhibitors of microRNA miR-21 function. Angew Chem Int Ed Engl 47:7482–7484
Young DD, Connelly CM, Grohmann C, Deiters A (2010) Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinoma. J Am Chem Soc 132:7976–7981
Shortridge MD, Walker MJ, Pavelitz T, Chen Y, Yang W, Varani G (2017) A macrocyclic peptide ligand binds the oncogenic microRNA-21 precursor and suppresses dicer processing. ACS Chem Biol 12:1611–1620
Chen Y, Yang F, Zubovic L, Pavelitz T, Yang W, Godin K, Walker M, Zheng S, Macchi P, Varani G (2016) Targeted inhibition of oncogenic miR-21 maturation with designed RNA-binding proteins. Nat Chem Biol 12:717–723
Velagapudi SP, Cameron MD, Haga CL, Rosenberg LH, Lafitte M, Duckett DR, Phinney DG, Disney MD (2016) Design of a small molecule against an oncogenic noncoding RNA. Proc Natl Acad Sci U S A 113:5898–5903
Costales MG, Haga CL, Velagapudi SP, Childs-Disney JL, Phinney DG, Disney MD (2017) Small molecule inhibition of microRNA-210 reprograms an oncogenic hypoxic circuit. J Am Chem Soc 139:3446–3455
Devi G, Zhou Y, Zhong Z, Toh D-FK, Chen G (2015) RNA triplexes: from structural principles to biological and biotech applications. Wiley Interdiscip Rev RNA 6:111–128
Li M, Zengeya T, Rozners E (2010) Short peptide nucleic acids bind strongly to homopurine tract of double helical RNA at pH 5.5. J Am Chem Soc 132:8676–8681
Zengeya T, Gupta P, Rozners E (2012) Triple helical recognition of RNA using 2-aminopyridine-modified PNA at physiologically relevant conditions. Angew Chem Int Ed Engl 51:12593–12596
Muse O, Zengeya T, Mwaura J, Hnedzko D, McGee DW, Grewer CT, Rozners E (2013) Sequence selective recognition of double-stranded RNA at physiologically relevant conditions using PNA-peptide conjugates. ACS Chem Biol 8:1683–1686
Hnedzko D, McGee DW, Karamitas YA, Rozners E (2017) Sequence-selective recognition of double-stranded RNA and enhanced cellular uptake of cationic nucleobase and backbone-modified peptide nucleic acids. RNA 23:58–69
Endoh T, Hnedzko D, Rozners E, Sugimoto N (2016) Nucleobase-modified PNA suppresses translation by forming a triple helix with a hairpin structure in mRNA in vitro and in cells. Angew Chem Int Ed Engl 55:899–903
Hildbrand S, Leumann C (1996) Enhancing DNA triple helix stability at neutral pH by the use of oligonucleotides containing a more basic deoxycytidine analog. Angew Chem Int Ed Engl 35:1968–1970
Hildbrand S, Blaser A, Parel SP, Leumann CJ (1997) 5-Substituted 2-aminopyridine C-nucleosides as protonated cytidine equivalents: increasing efficiency and specificity in DNA triple-helix formation. J Am Chem Soc 119:5499–5511
Bates PJ, Laughton CA, Jenkins TC, Capaldi DC, Roselt PD, Reese CB, Neidle S (1996) Efficient triple helix formation by oligodeoxyribonucleotides containing α- or β-2-amino-5-(2-deoxy-D-ribofuranosyl) pyridine residues. Nucleic Acids Res 24:4176–4184
Cassidy SA, Slickers P, Trent JO, Capaldi DC, Roselt PD, Reese CB, Neidle S, Fox KR (1997) Recognition of GC base pairs by triplex forming oligonucleotides containing nucleosides derived from 2-aminopyridine. Nucleic Acids Res 25:4891–4898
Rusling DA, Powers VEC, Ranasinghe RT, Wang Y, Osborne SD, Brown T, Fox KR (2005) Four base recognition by triplex-forming oligonucleotides at physiological pH. Nucleic Acids Res 33:3025–3032
Lou C, Shelbourne M, Fox KR, Brown T (2011) 2′-Amino-ethoxy-2-amino-3-methylpyridine in triplex-forming oligonucleotides: high affinity, selectivity and resistance to enzymatic degradation. Chemistry 17:14851–14856. S14851/14851-S14851/14827.
Lou C, Xiao Q, Tailor RR, Ben Gaied N, Gale N, Light ME, Fox KR, Brown T (2011) 2′-Substituted 2-amino-3-methylpyridine ribonucleosides in triplex-forming oligonucleotides: triplex stability is determined by chemical environment. Med Chem Commun 2:550–558
Hnedzko D, McGee DW, Rozners E (2016) Synthesis and properties of peptide nucleic acid labeled at the N-terminus with HiLyte Fluor 488 fluorescent dye. Bioorg Med Chem 24:4199–4205
Buchini S, Leumann CJ (2004) Stable and selective recognition of three base pairs in the parallel triple-helical DNA binding motif. Angew Chem Int Ed Engl 43:3925–3928
Ranasinghe RT, Rusling DA, Powers VEC, Fox KR, Brown T (2005) Recognition of CG inversions in DNA triple helices by methylated 3H-pyrrolo[2,3-d]pyrimidin-2(7H)-one nucleoside analogues. Chem Commun (Camb) (20):2555–2557
Eldrup AB, Dahl O, Nielsen PE (1997) A novel peptide nucleic acid monomer for recognition of thymine in triple-helix structures. J Am Chem Soc 119:11116–11117
Gupta P, Zengeya T, Rozners E (2011) Triple helical recognition of pyrimidine inversions in polypurine tracts of RNA by nucleobase-modified PNA. Chem Commun 47:11125–11127
Kim KT, Chang D, Winssinger N (2018) Double-stranded RNA-specific templated reaction with triplex forming PNA. Helv Chim Acta 101:e1700295
Kotikam V, Kennedy SD, MacKay JA, Rozners E (2019) Synthetic, Structural, and RNA Binding Studies on 2‐Aminopyridine‐Modified Triplex‐Forming Peptide Nucleic Acids. Chemistry – A European Journal 25(17):4367–4372
Acknowledgments
This work was supported by NIH grant GM071461 (to E.R.) and NSF grants CHE-1406433 and CHE-1708761 (to E.R.) and CHE-1708699 (to J.A.M.).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Brodyagin, N., Hnedzko, D., MacKay, J.A., Rozners, E. (2020). Nucleobase-Modified Triplex-Forming Peptide Nucleic Acids for Sequence-Specific Recognition of Double-Stranded RNA. In: Nielsen, P. (eds) Peptide Nucleic Acids. Methods in Molecular Biology, vol 2105. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0243-0_9
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0243-0_9
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0242-3
Online ISBN: 978-1-0716-0243-0
eBook Packages: Springer Protocols